An interview of Dr. Michael Tees and Dr. Fred Locke offering clinician views on CAR-T
WEST WARWICK, Rhode Island
A great interview of Dr. Michael Tees and Dr. Fred Locke by Arsalan Arif offering clinician views on current challenges and future opportunities for CAR-T (autologous + allogeneic).
Link to video: https://carttogether.com
Our takeaways? (1) There’s a move toward outpatient care and (2) unnecessary apheresis bottlenecks are still a thing. There is no good reason for apheresis to be a bottleneck in the delivery of a CAR-T cell therapy to every patient that needs one.
Every member of Blood Centers of America across 43 US states is keen to do everything in their power to ensure apheresis options exist so that safe, on-demand, and cost-effective apheresis collections can happen wherever they are needed, whenever they are needed.